C07F 9/564
Three-membered rings
C07F9/564 (Three-membered rings) appears on 46 US grants and 38 published applications in this corpus.
Search patents in C07F- Granted patents
- 46
- Published applications
- 38
- Assignees
- 31
- Inventors
- 114
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 2 |
| 2003 | 1 | 0 |
| 2004 | 1 | 2 |
| 2005 | 2 | 2 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 2 |
| 2010 | 1 | 0 |
| 2011 | 1 | 1 |
| 2012 | 1 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 3 |
| 2016 | 2 | 1 |
| 2017 | 1 | 1 |
| 2018 | 2 | 4 |
| 2019 | 2 | 1 |
| 2020 | 3 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 6 |
| 2023 | 0 | 3 |
| 2024 | 1 | 2 |
| 2025 | 1 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Fluorine-containing compound and anti-cancer medical use thereof7 Apr 2026US 12,595,275 B2Ascentawits Pharmaceuticals, Ltd.
- Flow synthesis process for the production of oseltamivir3 Jun 2025US 12,319,639 B2Nelson Mandela University
- Process for making levoamphetamine11 Jun 2024US 12,006,275 B2Pharmapotheca A, Inc.
- DNA alkylating agents8 Sep 2020US 10,766,914 B2Obi Pharma, Inc.
- Aziridine containing DNA alkylating agents2 Jun 2020US 10,668,047 B2Molecular Templates, Inc.
- Phosphoramidate compounds and uses thereof18 Jun 2026US 2026/0167656 A1Allorion Therapeutics Inc
- Akr1c3-activated dna alkylating agent, and medical application thereof11 Jun 2026US 2026/0159536 A1Ascentawits Pharmaceuticals, Ltd.
- A deuterated compound, and preparation method and use thereof2 Oct 2025US 2025/0304606 A2Ascentawits Pharmaceuticals, Ltd.
- Synthesis Process of X-IPM, Stable Crystal Form and Application Thereof9 Jan 2025US 2025/0011348 A1Ascentawits Pharmaceuticals, Ltd.
- Combination therapy by using akr1c3-activated compound with immune checkpoint inhibitor4 Jul 2024US 2024/0216401 A1
Most cited
By later US patents
- Immune-stimulating and cancerostatic 1-acyl-2-cyanoaziridines18US 4,267,174 ABoehringer Mannheim GmbH · 1981
- Gem-diphosphonic acids, and pharmaceutical compositions containing them14US 5,300,671 ABoehringer Mannheim Italia S.p.A. · 1994
- Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same11US 6,686,477 B2Eastman Chemical Company · 2004
- Inhibitors of matrix metallaproteinases9US 7,928,127 B2Notre Dame University · 2011
- Process for the preparation of an oxirane, azirdine or cyclopropane7US 5,703,246 AZeneca Limited · 1997